Key statistics
On Friday, Castle Biosciences Inc (CSTL:NMQ) closed at 31.47, -3.26% below its 52-week high of 32.53, set on Sep 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 30.58 |
---|---|
High | 32.00 |
Low | 29.99 |
Bid | 31.03 |
Offer | 32.40 |
Previous close | 30.53 |
Average volume | 377.33k |
---|---|
Shares outstanding | 27.74m |
Free float | 26.82m |
P/E (TTM) | -- |
Market cap | 872.88m USD |
EPS (TTM) | -0.1346 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Castle Biosciences’ Chief Operating Officer Kristen Oelschlager Named Arizona Bioscience Leader of the Year
- DecisionDx®-Melanoma Can Identify Melanoma Patients with Low Risk of Sentinel Lymph Node Positivity Who May Safely Forego Biopsy Surgery, New Independent Study Affirms
- Study Confirms the Ability of Castle Biosciences' DecisionDx®-SCC Test to Predict Likelihood of Benefit from Adjuvant Radiation Therapy in Patients with High-Risk Cutaneous Squamous Cell Carcinoma
- Castle Biosciences to Participate in Upcoming Investor Conferences
- Castle Biosciences Reports Second Quarter 2024 Results
- Castle Biosciences to Present at the Canaccord Genuity 44th Annual Growth Conference
- Castle Biosciences and Skin Cancer Survivor Teddi Mellencamp Arroyave Launch Campaign to Increase Awareness of Melanoma
- Castle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024
- Castle Biosciences Honored with Top Workplaces Awards
More ▼